Author name: cultivate(MD)

cultivate post

cultivate(MD) Announces Investment Into Medical Ingenuities

HOLLAND, Mich., May 24, 2021 – Genesis Innovation Group\’s cultivate(MD) Seed II Fund, a fund focused on investments into early-stage healthcare companies with innovative technologies, announces that one of their portfolio companies, Wheaton, IL-based Medical Ingenuities, LLC, a medical device company that has developed a novel PH Band™ radial artery occlusion device, has closed its […]

cultivate(MD) Announces Investment Into Medical Ingenuities Read More »

shoulder innovations genesis news

Shoulder Innovations Announces Exclusive License Agreement for Genesis Software Innovations PreView Shoulder™ Software

HOLLAND, Mich., May 10th, 2021 – Shoulder Innovations (SI), an emerging leader in the development of shoulder replacement systems, announced today that it has signed an exclusive license agreement for Genesis Software Innovation‘s “GSI“ PreView Shoulder™ Arthroplasty Planning Software, which recently achieved FDA 510(k) clearance. This clearance is the first musculoskeletal solution under the FDA’s

Shoulder Innovations Announces Exclusive License Agreement for Genesis Software Innovations PreView Shoulder™ Software Read More »

preview shoulder software

Genesis Software Innovations Announces FDA 510(K) Clearance for Preview™ 3D Shoulder Arthroplasty Planning Software

GRAND RAPIDS, Mich., May 5th, 2021—Genesis Software Innovations “GSI,” a company that has created an innovative foundational platform solution in the orthopedic space, announced today that they have received FDA clearance for their Preview™ 3D Shoulder Arthroplasty Planning Software. The Preview™ Shoulder Software is a breakthrough tool for orthopedic surgeons to develop pre-operative shoulder plans

Genesis Software Innovations Announces FDA 510(K) Clearance for Preview™ 3D Shoulder Arthroplasty Planning Software Read More »

cultivate post

Medical Ingenuities Receives FDA 510(k) Clearance for PH Band

Novel radial artery occlusion device removes the guesswork from achieving Patent Hemostasis Holland, Mich. – December 9th, 2020 – Genesis Innovation Group’s cultivate(MD) Capital Fund II LP, a fund focused on investments into early stage healthcare companies with innovative technologies, announces that one of their portfolio companies, Wheaton, IL-based Medical Ingenuities, a medical device company

Medical Ingenuities Receives FDA 510(k) Clearance for PH Band Read More »

Embody's logo capturing the mission of repair, regenerate, and restore.

Embody, Inc. Announces FDA 510(k) Clearance of TAPESTRY® Biointegrative Implant for Tendon and Ligament Repair

Holland, Mich. – October 29, 2020 – Genesis Innovation Group’s cultivate(MD) Seed Fund, a fund focused on investments into early-stage healthcare companies with innovative technologies, announces that one of their portfolio companies, Norfolk, VA based Embody, Inc. has received FDA 510(k) clearance for their TAPESTRY® Biointegrative Implant for Tendon and Ligament Repair.

Embody, Inc. Announces FDA 510(k) Clearance of TAPESTRY® Biointegrative Implant for Tendon and Ligament Repair Read More »